The Chemours Company Announces Private Offering of $600,000,000 of Senior Notes Due 2034

Rhea-AI Summary

Chemours (NYSE: CC) announced a proposed private offering of $600,000,000 aggregate principal amount of senior notes due 2034 on February 26, 2026. The Notes will be senior unsecured obligations and guaranteed by a Chemours subsidiary.

The company intends to use net proceeds to fund the redemption of its outstanding 5.375% senior notes due 2027 and to fund the redemption or repurchase of a portion of its outstanding 5.750% senior notes due 2028. The offering is being made only to qualified institutional buyers under Rule 144A or to non-U.S. persons under Regulation S and the Notes have not been registered under the Securities Act.

Positive

• Proposed $600,000,000 senior notes due 2034 announced
• Proceeds targeted to redeem 5.375% notes due 2027
• Planned reduction or repurchase of portion of 5.750% notes due 2028

Negative

• New Notes will be senior unsecured obligations (no collateral)
• Offering limited to Rule 144A/Reg S investors, restricting public liquidity
• Redemptions will require significant cash outflow to retire near-term debt

News Market Reaction – CC

-3.88%

19 alerts

-3.88% Session close to close

+5.7% Peak in 30 hr 15 min

$2.74B Market Cap

1.0x Rel. Volume

In the Feb 26 session, CC declined 3.88%, reflecting a moderate negative market reaction. Argus tracked a peak move of +5.7% during that session. Our momentum scanner triggered 19 alerts that day, indicating notable trading interest and price volatility.

Data tracked by StockTitan Argus on the day of publication.

Market Context

This announcement details a new $600,000,000 senior notes due 2034 offering, with proceeds earmarked...

Analysis

This announcement details a new $600,000,000 senior notes due 2034 offering, with proceeds earmarked to redeem 5.375% notes due 2027 and partially address 5.750% notes due 2028. It continues Chemours’ pattern of using private offerings with Rule 144A and Regulation S structures to refinance existing debt. Investors may monitor future filings and earnings updates for impacts on leverage, interest costs, and overall balance sheet flexibility.

Key Figures

New senior notes: $600,000,000 Maturity: 2034 Coupon on 2027 notes: 5.375% +3 more

6 metrics

New senior notes $600,000,000 Aggregate principal amount of new senior notes due 2034

Maturity 2034 Due date of newly offered senior notes

Coupon on 2027 notes 5.375% Coupon of senior notes due 2027 to be redeemed

Maturity of 2027 notes 2027 Existing 5.375% senior notes maturity year

Coupon on 2028 notes 5.750% Coupon of senior notes due 2028 to be partly redeemed/repurchased

Maturity of 2028 notes 2028 Existing 5.750% senior notes maturity year

Previous Private placement,offering Reports

3 past events · Latest: Nov 27 (Neutral)

Same Type Pattern 3 events

Date	Event	Sentiment	24h Move	Catalyst
Nov 27	Debt offering completion	Neutral	-0.4%	Completed private offering of $600M 8.000% senior unsecured notes due 2033.
Nov 13	Debt pricing	Neutral	+0.8%	Priced $600M private offering of 8.000% senior notes due 2033.
Nov 13	Debt offering launch	Neutral	-0.7%	Announced plan to offer $600M senior notes due 2033 for debt redemption.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Prior private offerings of $600M senior notes produced muted reactions (average move -0.09%), suggesting this type of capital markets action has historically been absorbed calmly.

Recent Company History

Over the past cycles of similar financing news, Chemours announced and priced multiple $600 million senior note offerings, all aimed at refinancing existing euro-denominated 4.000% notes due 2026. Market reactions to these capital structure moves were modest, ranging from about -0.73% to 0.84%. Today’s planned 2034 notes to refinance 2027 and 2028 issues continues that refinancing pattern, fitting within the company’s ongoing balance sheet management activity.

Key Terms

senior notes, senior unsecured obligations, qualified institutional buyers, Rule 144A, +3 more

7 terms

senior notes financial

"announced that it intends to offer $600,000,000 aggregate principal amount of new senior notes due 2034"

Senior notes are a type of loan that a company borrows from investors, promising to pay it back with interest. They are called "senior" because in case the company faces financial trouble, these lenders are paid back before others. This makes senior notes safer for investors compared to other types of loans or bonds.

senior unsecured obligations financial

"The Notes will be senior unsecured obligations of Chemours and will be guaranteed"

Senior unsecured obligations are loans or bonds that a company promises to pay back with its own money, but without any special guarantees or collateral. If the company runs into financial trouble, these debts are paid after other debts with priority, meaning they are less protected but still important. They matter because they show how risky it is to lend money to a company.

qualified institutional buyers financial

"offered only to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A"

Qualified institutional buyers are large organizations, like big investment firms or banks, that are allowed to buy certain types of investment opportunities not available to everyday investors. Their size and experience matter because it ensures they understand and can handle complex financial deals, making markets more efficient and secure.

Rule 144A regulatory

"qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933"

Rule 144A is a regulation that makes it easier for companies to sell private bonds to large investors without going through all the usual rules that apply to public sales. It matters because it helps companies raise money more quickly and privately, often attracting big investors looking for special deals.

Regulation S regulatory

"outside the United States to non-U.S. persons in compliance with Regulation S under the Securities Act"

Regulation S is a set of rules that allows companies to sell securities (like shares or bonds) to investors outside the United States without having to follow all U.S. securities laws. It matters because it makes it easier for companies to raise money from international investors while still complying with U.S. regulations.

private offering memorandum financial

"Any offers of the Notes and related guarantees are being made only by means of a private offering memorandum"

A private offering memorandum is a detailed disclosure document used when securities are sold privately rather than on public markets; it lays out what the investment is, how it works, the fees and terms, the company’s financials, and the main risks. Think of it as a full information packet or brochure you get before buying a complex product—investors use it to compare opportunities, spot red flags, understand legal rights and limits on resale, and decide whether the potential reward justifies the risk.

registered under the Securities Act regulatory

"The Notes and related guarantees have not been registered under the Securities Act, or the securities laws"

Means a company has filed required paperwork with the securities regulator so a stock or other security can be offered or sold to the public; the filing makes key financial and business information available to investors. Like handing out a detailed product label before sale, registration gives buyers reliable facts, legal protections and usually easier resale of the security, which helps investors assess risk and compare opportunities.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WILMINGTON, Del., Feb. 26, 2026 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC) today announced that it intends to offer $600,000,000 aggregate principal amount of new senior notes due 2034 (the "Notes"), subject to market and other conditions. The Notes will be senior unsecured obligations of Chemours and will be guaranteed by a subsidiary of Chemours. Chemours intends to use the net proceeds from the offering to fund the redemption of its outstanding 5.375% senior notes due 2027 and to fund the redemption or repurchase of a portion of its outstanding 5.750% senior notes due 2028. 

The Notes and related guarantees are being offered only to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"), or outside the United States to non-U.S. persons in compliance with Regulation S under the Securities Act. This press release shall not constitute an offer to sell or the solicitation of an offer to buy the Notes and related guarantees. Any offers of the Notes and related guarantees are being made only by means of a private offering memorandum. 

The Notes and related guarantees have not been registered under the Securities Act, or the securities laws of any other jurisdiction, and may not be offered or sold in the United States without registration or an applicable exemption from registration requirements.   

About The Chemours Company

The Chemours Company (NYSE: CC) is a global leader in providing industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and advanced electronics, general industrial, and oil and gas. Through our three businesses – Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials – we deliver application expertise and chemistry-based innovations that solve customers' biggest challenges. Our flagship products are sold under prominent brands such as Opteon™, Freon™, Ti-Pure™, Nafion™, Teflon™, Viton™, and Krytox™. Headquartered in Wilmington, Delaware and listed on the NYSE under the symbol CC, Chemours has approximately 5,700 employees and 28 manufacturing sites and serves approximately 2,400 customers in approximately 110 countries. 

Forward-Looking Statements 

This press release contains forward-looking statements, within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical or current fact. The words "believe," "expect," "will," "anticipate," "plan," "estimate," "target," "project" and similar expressions, among others, generally identify "forward-looking statements," which speak only as of the date such statements were made. These forward-looking statements may address, among other things, the offering of Notes and Chemours' intended use of the net proceeds therefrom, which are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These risks and uncertainties include, but are not limited to, the ability of Chemours to complete the offering on favorable terms, if at all, and general market conditions which might affect the offering. Forward-looking statements are based on certain assumptions and expectations of future events that may not be accurate or realized. These statements are not guarantees of future performance. Forward-looking statements also involve risks and uncertainties that are beyond Chemours' control. Matters outside Chemours' control, including general economic conditions, geopolitical conditions, changes in laws and regulations in the United States or other jurisdictions in which we operate, and global health events and weather events, have affected or may affect Chemours' business and operations and may or may continue to hinder Chemours' ability to provide goods and services to customers, cause disruptions in Chemours' supply chains such as through strikes, labor disruptions or other events, adversely affect Chemours'  business partners, significantly reduce the demand for Chemours' products, adversely affect the health and welfare of Chemours' personnel or cause other unpredictable events. Additionally, there may be other risks and uncertainties that Chemours is unable to identify at this time or that Chemours does not currently expect to have a material impact on its business. Factors that could cause or contribute to these differences include whether the offering of Notes is completed and other risks, uncertainties and other factors discussed in Chemours' filings with the U.S. Securities and Exchange Commission, including in Chemours' Annual Report on Form 10-K for the year ended December 31, 2025. Chemours assumes no obligation to revise or update any forward-looking statement for any reason, except as required by law.

CONTACTS: 

INVESTORS 
Brandon Ontjes
Vice President, Investor Relations 
+1.302.773.3309  
investor@chemours.com

NEWS MEDIA 
Cassie Olszewski
Media Relations & Reputation Leader
+1.302.219.7140
media@chemours.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/the-chemours-company-announces-private-offering-of-600-000-000-of-senior-notes-due-2034--302698473.html

SOURCE The Chemours Company

FAQ

What did Chemours (CC) announce on February 26, 2026 about new debt?

Chemours announced a proposed private offering of $600,000,000 senior notes due 2034. According to the company, the Notes will be senior unsecured and guaranteed by a subsidiary and are offered only to qualified institutional buyers or non-U.S. persons.

How will Chemours (CC) use proceeds from the $600,000,000 2034 notes?

Chemours intends to use net proceeds to redeem its 5.375% senior notes due 2027 and to redeem or repurchase part of its 5.750% notes due 2028. According to the company, this is the stated purpose of the offering.

Who can buy the Chemours (CC) senior notes due 2034 in this offering?

The Notes are being offered only to persons reasonably believed to be qualified institutional buyers under Rule 144A. According to the company, non-U.S. persons may participate under Regulation S outside the United States.

Are the Chemours (CC) 2034 notes registered under the Securities Act?

No, the Notes and related guarantees have not been registered under the Securities Act. According to the company, they may not be offered or sold in the U.S. without registration or an applicable exemption.

Will the new Chemours (CC) notes be secured or guaranteed?

The Notes will be senior unsecured obligations and will be guaranteed by a Chemours subsidiary. According to the company, the guarantees accompany the unsecured senior notes in the private offering.